The results of two large, randomized clinical trials published October 5, 2006, in the New England Journal of Medicine demonstrate that the drug ranibizumab (Lucentis) is an effective treatment for neovascular macular degeneration, a complication of age-related macular degeneration that leads to the vast majority of legal blindness associated with the disorder.
A major veterans’ group says more attention should be paid to the eyes of injured combat veterans evacuated from Iraq and Afghanistan because of a possible link between undiagnosed cases of head injury and eye problems.
Patients given eye treatment for free by the government in Guwahati have suffered infection and doctors say the affected eye should be removed.
The antibiotic doxycycline is proving an effective treatment for a lymphoma of the eye linked to chlamydia infection, Italian researchers report.
World biggest drug maker buys genetic eye treatment for blindness from Israeli biotech firm
The Vietnam Support Children Fund and ORBIS Vietnam signed a project “gift of light for children” in Hanoi on October 2.
 |  |  |  |  |  |  |
 |  |  |  |  |  |  |
 |  |  |  |  |  |  |
 |  |  |  |  |  |  |
 |  |  |  |  | ||
| Plugin by Taragana | ||||||
You are currently browsing the The Eye Care Blog weblog archives for October, 2006.
| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| « Sep | Nov » | |||||
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 | 31 | |||||